Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Host Competency of the Multimammate Rat Mastomys natalensis Demonstrated by Prolonged Spirochetemias with the African Relapsing Fever Spirochete Borrelia crocidurae.

Boardman K, Rosenke K, Safronetz D, Feldmann H, Schwan TG.

Am J Trop Med Hyg. 2019 Dec;101(6):1272-1275. doi: 10.4269/ajtmh.19-0590.

PMID:
31674298
2.

Animal models for Lassa virus infection.

Tang-Huau TL, Feldmann H, Rosenke K.

Curr Opin Virol. 2019 Aug;37:112-117. doi: 10.1016/j.coviro.2019.07.005. Epub 2019 Aug 20. Review.

PMID:
31442921
3.

Human Polyclonal Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal Zaire Ebolavirus Challenge in Rhesus Macaques.

Rosenke K, Bounds CE, Hanley PW, Saturday G, Sullivan E, Wu H, Jiao JA, Feldmann H, Schmaljohn C, Safronetz D.

J Infect Dis. 2018 Nov 22;218(suppl_5):S658-S661. doi: 10.1093/infdis/jiy430.

4.

Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.

Hawman DW, Haddock E, Meade-White K, Williamson B, Hanley PW, Rosenke K, Komeno T, Furuta Y, Gowen BB, Feldmann H.

Antiviral Res. 2018 Sep;157:18-26. doi: 10.1016/j.antiviral.2018.06.013. Epub 2018 Jun 21.

PMID:
29936152
5.

Use of Favipiravir to Treat Lassa Virus Infection in Macaques.

Rosenke K, Feldmann H, Westover JB, Hanley PW, Martellaro C, Feldmann F, Saturday G, Lovaglio J, Scott DP, Furuta Y, Komeno T, Gowen BB, Safronetz D.

Emerg Infect Dis. 2018 Sep;24(9):1696-1699. doi: 10.3201/eid2409.180233. Epub 2018 Sep 17.

6.

The Effect of Plasmodium on the Outcome of Ebola Virus Infection in a Mouse Model.

Rosenke K, Mercado-Hernandez R, Cronin J, Conteh S, Duffy P, Feldmann H, de Wit E.

J Infect Dis. 2018 Nov 22;218(suppl_5):S434-S437. doi: 10.1093/infdis/jiy236.

7.

Seroprevalence of Rift Valley Fever Virus Antibodies in Cattle in Mali, 2005-2014.

Subudhi S, Dakouo M, Sloan A, Stein DR, Grolla A, Jones S, Dibernardo A, Rosenke K, Sas M, Traore A, Lindsay R, Groschup MH, Misra V, Feldmann H, Sogoba N, Safronetz D, Niang M.

Am J Trop Med Hyg. 2018 Mar;98(3):872-874. doi: 10.4269/ajtmh.17-0841. Epub 2018 Jan 18.

8.

Serosurvey of Crimean-Congo Hemorrhagic Fever Virus in Cattle, Mali, West Africa.

Maiga O, Sas MA, Rosenke K, Kamissoko B, Mertens M, Sogoba N, Traore A, Sangare M, Niang M, Schwan TG, Maiga HM, Traore SF, Feldmann H, Safronetz D, Groschup MH.

Am J Trop Med Hyg. 2017 Jun;96(6):1341-1345. doi: 10.4269/ajtmh.16-0818.

9.

Domestic Pig Unlikely Reservoir for MERS-CoV.

de Wit E, Feldmann F, Horne E, Martellaro C, Haddock E, Bushmaker T, Rosenke K, Okumura A, Rosenke R, Saturday G, Scott D, Feldmann H.

Emerg Infect Dis. 2017 Jun;23(6):985-988. doi: 10.3201/eid2306.170096. Epub 2017 Jun 15.

10.

Latent murine leukemia virus infection characterized by the release of non-infectious virions.

Boi S, Van Dis E, Hansen EJ, Rosenke K, Peterson KE, Ferrell ME, Evans LH.

Virology. 2017 Jun;506:19-27. doi: 10.1016/j.virol.2017.03.004. Epub 2017 Mar 11.

11.

Annual Incidence of Lassa Virus Infection in Southern Mali.

Safronetz D, Sogoba N, Diawara SI, Bane S, Rosenke K, Maiga O, Boisen M, Garry RF, Branco LM, Lindsay LR, Traoré SF, Feldmann H, Doumbia S.

Am J Trop Med Hyg. 2017 Apr;96(4):944-946. doi: 10.4269/ajtmh.16-0821. Epub 2017 Jan 16.

12.

Reply to Colebunders.

Rosenke K, Adjemian J, Munster VJ, Strong JE, Sprecher A, Feldmann H, de Wit E.

Clin Infect Dis. 2017 Jan 15;64(2):232. doi: 10.1093/cid/ciw734. Epub 2016 Nov 9. No abstract available.

13.

Laboratory Response to 2014 Ebola Virus Outbreak in Mali.

Diarra B, Safronetz D, Sarro YD, Kone A, Sanogo M, Tounkara S, Togo AC, Daou F, Maiga AI, Dao S, Rosenke K, Falzarano D, Doumbia S, Zoon KC, Polis M, Siddiqui S, Sow S, Schwan TG, Feldmann H, Diallo S, Koita OA.

J Infect Dis. 2016 Oct 15;214(suppl 3):S164-S168.

14.

Endogenous retroviruses mobilized during friend murine leukemia virus infection.

Boi S, Rosenke K, Hansen E, Hendrick D, Malik F, Evans LH.

Virology. 2016 Dec;499:136-143. doi: 10.1016/j.virol.2016.07.009. Epub 2016 Sep 19.

15.

Plasmodium Parasitemia Associated With Increased Survival in Ebola Virus-Infected Patients.

Rosenke K, Adjemian J, Munster VJ, Marzi A, Falzarano D, Onyango CO, Ochieng M, Juma B, Fischer RJ, Prescott JB, Safronetz D, Omballa V, Owuor C, Hoenen T, Groseth A, Martellaro C, van Doremalen N, Zemtsova G, Self J, Bushmaker T, McNally K, Rowe T, Emery SL, Feldmann F, Williamson BN, Best SM, Nyenswah TG, Grolla A, Strong JE, Kobinger G, Bolay FK, Zoon KC, Stassijns J, Giuliani R, de Smet M, Nichol ST, Fields B, Sprecher A, Massaquoi M, Feldmann H, de Wit E.

Clin Infect Dis. 2016 Oct 15;63(8):1026-33. doi: 10.1093/cid/ciw452. Epub 2016 Aug 15.

16.

Clinical Chemistry of Patients With Ebola in Monrovia, Liberia.

de Wit E, Kramer S, Prescott J, Rosenke K, Falzarano D, Marzi A, Fischer RJ, Safronetz D, Hoenen T, Groseth A, van Doremalen N, Bushmaker T, McNally KL, Feldmann F, Williamson BN, Best SM, Ebihara H, Damiani IA, Adamson B, Zoon KC, Nyenswah TG, Bolay FK, Massaquoi M, Sprecher A, Feldmann H, Munster VJ.

J Infect Dis. 2016 Oct 15;214(suppl 3):S303-S307. Epub 2016 Jul 28.

17.

Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015.

de Wit E, Rosenke K, Fischer RJ, Marzi A, Prescott J, Bushmaker T, van Doremalen N, Emery SL, Falzarano D, Feldmann F, Groseth A, Hoenen T, Juma B, McNally KL, Ochieng M, Omballa V, Onyango CO, Owuor C, Rowe T, Safronetz D, Self J, Williamson BN, Zemtsova G, Grolla A, Kobinger G, Rayfield M, Ströher U, Strong JE, Best SM, Ebihara H, Zoon KC, Nichol ST, Nyenswah TG, Bolay FK, Massaquoi M, Feldmann H, Fields B.

J Infect Dis. 2016 Oct 15;214(suppl 3):S169-S176. Epub 2016 Jun 21.

18.

Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali.

Sogoba N, Rosenke K, Adjemian J, Diawara SI, Maiga O, Keita M, Konaté D, Keita AS, Sissoko I, Boisen M, Nelson D, Oottamasathien D, Millett M, Garry RF, Branco LM, Traoré SF, Doumbia S, Feldmann H, Safronetz D.

Emerg Infect Dis. 2016 Apr;22(4):657-63. doi: 10.3201/eid2204.151814.

19.

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak.

de Wit E, Falzarano D, Onyango C, Rosenke K, Marzi A, Ochieng M, Juma B, Fischer RJ, Prescott JB, Safronetz D, Omballa V, Owuor C, Hoenen T, Groseth A, van Doremalen N, Zemtsova G, Self J, Bushmaker T, McNally K, Rowe T, Emery SL, Feldmann F, Williamson B, Nyenswah TG, Grolla A, Strong JE, Kobinger G, Stroeher U, Rayfield M, Bolay FK, Zoon KC, Stassijns J, Tampellini L, de Smet M, Nichol ST, Fields B, Sprecher A, Feldmann H, Massaquoi M, Munster VJ.

Emerg Infect Dis. 2016 Feb;22(2):323-6. doi: 10.3201/eid2202.151656.

20.

Vectorborne Infections, Mali.

Safronetz D, Sacko M, Sogoba N, Rosenke K, Martellaro C, Traoré S, Cissé I, Maiga O, Boisen M, Nelson D, Oottamasathien D, Millett M, Garry RF, Branco LM, Doumbia S, Feldmann H, Traoré MS.

Emerg Infect Dis. 2016 Feb;22(2):340-2. doi: 10.3201/eid2202.150688. No abstract available.

21.

Nanopore Sequencing as a Rapidly Deployable Ebola Outbreak Tool.

Hoenen T, Groseth A, Rosenke K, Fischer RJ, Hoenen A, Judson SD, Martellaro C, Falzarano D, Marzi A, Squires RB, Wollenberg KR, de Wit E, Prescott J, Safronetz D, van Doremalen N, Bushmaker T, Feldmann F, McNally K, Bolay FK, Fields B, Sealy T, Rayfield M, Nichol ST, Zoon KC, Massaquoi M, Munster VJ, Feldmann H.

Emerg Infect Dis. 2016 Feb;22(2):331-4. doi: 10.3201/eid2202.151796.

22.

The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.

Safronetz D, Rosenke K, Westover JB, Martellaro C, Okumura A, Furuta Y, Geisbert J, Saturday G, Komeno T, Geisbert TW, Feldmann H, Gowen BB.

Sci Rep. 2015 Oct 12;5:14775. doi: 10.1038/srep14775.

23.

A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses.

Safronetz D, Mire C, Rosenke K, Feldmann F, Haddock E, Geisbert T, Feldmann H.

PLoS Negl Trop Dis. 2015 Apr 17;9(4):e0003736. doi: 10.1371/journal.pntd.0003736. eCollection 2015 Apr.

24.

Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences.

Hoenen T, Safronetz D, Groseth A, Wollenberg KR, Koita OA, Diarra B, Fall IS, Haidara FC, Diallo F, Sanogo M, Sarro YS, Kone A, Togo AC, Traore A, Kodio M, Dosseh A, Rosenke K, de Wit E, Feldmann F, Ebihara H, Munster VJ, Zoon KC, Feldmann H, Sow S.

Science. 2015 Apr 3;348(6230):117-9. doi: 10.1126/science.aaa5646. Epub 2015 Mar 26. Erratum in: Science. 2015 May 22;348(6237):aac5674.

25.

Incorporation of mouse APOBEC3 into murine leukemia virus virions decreases the activity and fidelity of reverse transcriptase.

Boi S, Kolokithas A, Shepard J, Linwood R, Rosenke K, Van Dis E, Malik F, Evans LH.

J Virol. 2014 Jul;88(13):7659-62. doi: 10.1128/JVI.00967-14. Epub 2014 Apr 9.

26.

Profound amplification of pathogenic murine polytropic retrovirus release from coinfected cells.

Rosenke K, Lavignon M, Malik F, Kolokithas A, Hendrick D, Virtaneva K, Peterson K, Evans LH.

J Virol. 2012 Jul;86(13):7241-8. doi: 10.1128/JVI.00225-12. Epub 2012 Apr 18.

27.

The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3.

Kolokithas A, Rosenke K, Malik F, Hendrick D, Swanson L, Santiago ML, Portis JL, Hasenkrug KJ, Evans LH.

J Virol. 2010 Oct;84(20):10933-6. doi: 10.1128/JVI.01023-10. Epub 2010 Aug 11.

28.

The presence of p53 influences the expression of multiple human cytomegalovirus genes at early times postinfection.

Hannemann H, Rosenke K, O'Dowd JM, Fortunato EA.

J Virol. 2009 May;83(9):4316-25. doi: 10.1128/JVI.02075-08. Epub 2009 Feb 18.

29.

Mobilization of endogenous retroviruses in mice after infection with an exogenous retrovirus.

Evans LH, Alamgir AS, Owens N, Weber N, Virtaneva K, Barbian K, Babar A, Malik F, Rosenke K.

J Virol. 2009 Mar;83(6):2429-35. doi: 10.1128/JVI.01926-08. Epub 2008 Dec 30.

30.

Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection.

Luo MH, Rosenke K, Czornak K, Fortunato EA.

J Virol. 2007 Feb;81(4):1934-50. Epub 2006 Dec 6. Erratum in: J Virol. 2007 Jul;81(13):7326. J Virol. 2011 Mar;85(6):3043.

31.

Potential role for p53 in the permissive life cycle of human cytomegalovirus.

Casavant NC, Luo MH, Rosenke K, Winegardner T, Zurawska A, Fortunato EA.

J Virol. 2006 Sep;80(17):8390-401.

32.
34.

Supplemental Content

Loading ...
Support Center